| Announed Date |
Target/Issuer |
Transaction Type |
Buyer/Investor |
Txn Value |
Implied TEV |
| - |
Imclone Systems Inc. |
Merger/Acquisition |
Bristol-Myers Squibb Co. |
4,929 |
4,857 |
| - |
Biogen Idec Inc. |
Shelf Registration |
- |
- |
- |
| 7/22/2008 |
Arius Research Inc. |
Merger/Acquisition |
Roche Holding AG |
181 |
172 |
| 7/22/2008 |
Mirus Bio Corporation |
Merger/Acquisition |
Roche Holding AG |
125 |
125 |
| - |
Genentech Inc. |
Merger/Acquisition |
Roche Holdings, Inc. |
43,638 |
93,891 |
| 7/3/2008 |
Cellectis |
Private Placement |
Regeneron Pharmaceuticals Inc. |
- |
- |
| - |
Regeneron Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| 6/26/2008 |
ZymoGenetics, Inc. |
Private Placement |
Deerfield Management Company L.P. |
- |
- |
| - |
Affymetrix Inc. |
Shelf Registration |
- |
- |
- |
| 6/15/2008 |
Akzo Nobel NV, Para and Crown Diamond Brands in Canada |
Merger/Acquisition |
General Paint Corp. |
- |
- |
| - |
Gilead Sciences Inc. |
Shelf Registration |
- |
- |
- |
| 6/11/2008 |
Applera Corp-Applied Biosystems Group (nka:Applied Biosystems Inc.) |
Merger/Acquisition |
Invitrogen Corp. |
6,523 |
6,158 |
| - |
Amylin Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| 5/29/2008 |
Navitas Pharma, Inc. |
Merger/Acquisition |
Gilead Sciences Inc. |
- |
- |
| 5/27/2008 |
Amaxa Biosystems GmbH |
Merger/Acquisition |
Lonza Group AG |
- |
- |
| 5/26/2008 |
AstraZeneca plc, Portfolio of 16 Prescription Drugs |
Merger/Acquisition |
Biophausia AB |
535 |
535 |
| - |
Chugai Pharmaceutical Co. Ltd. |
Merger/Acquisition |
Roche Holding AG |
95,029 |
837,938 |
| - |
ISIS Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| 5/21/2008 |
SkyePharma plc |
Buyback |
- |
- |
- |
| 5/19/2008 |
Baxter International Inc. |
Public Offering |
- |
- |
- |
| - |
Harvard Bioscience Inc. |
Shelf Registration |
- |
- |
- |
| - |
Vertex Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| - |
Vertex Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| - |
Myriad Genetics Inc. |
Shelf Registration |
- |
- |
- |
| - |
Wyeth |
Shelf Registration |
- |
- |
- |
| - |
Wyeth |
Shelf Registration |
- |
- |
- |
| 4/24/2008 |
AstraZeneca plc |
Buyback |
- |
- |
- |
| 4/22/2008 |
Cangene Corp. |
Buyback |
- |
- |
- |
| 4/20/2008 |
Amgen Inc. |
Public Offering |
- |
- |
- |
| 4/20/2008 |
Amgen Inc. |
Public Offering |
- |
- |
- |
| - |
Affymax, Inc. |
Shelf Registration |
- |
- |
- |
| - |
Amgen Inc. |
Shelf Registration |
- |
- |
- |
| 4/16/2008 |
AVANT Immunotherapeutics, Inc., Exclusive Worldwide License to CDX-110 |
Merger/Acquisition |
Pfizer Inc. |
430 |
430 |
| 4/22/2008 |
Sirtris Pharmaceuticals, Inc. |
Merger/Acquisition |
SmithKline Beecham Corporation |
727 |
620 |
| 4/7/2008 |
Washington Mutual Inc. |
Private Placement |
ACE European Group; ACE Property and Casualty Insurance Company; AIG SunAmerica Asset Management Corp.; Alberta Teachers' Retirement Fund Board; AllianceBernstein L.P.; AllianceBernstein Tax-Managed Balanced Wealth Strategy; AllianceBernstein Tax-Managed Wealth Appreciation Strategy; AllianceBernstein Tax-Managed Wealth Preservation Strategy; AllianceBernstein Value Fund; American Airlines Master Fixed Benefit Pension Plan Trust; American Beacon Balanced Fund; American Beacon Funds - Large Cap Value Fund; American Funds Insurance Series - Blue Chip Income and Growth Fund; American Funds Insurance Series - Growth-Income Fund; American Hospital Association Inc; American University Endowment, The; Asstel Lebensversicherung AG; AST Investment Services, Inc.; AST Large-Cap Value Portfolio; AST T. Rowe Price Asset Allocation Portfolio; Austin Presbyterian Theological Seminary Inc; AustralianSuper Pty Ltd; Avon Products Inc.; AXA Premier VIP Trust - Multimanager Large Cap Value Portfolio; Baltimore City Fire and Police Employees’ Retirement System; Barrow, Hanley, Mewhinney & Strauss, Inc.; Bay Pond Investors Bermuda L.P; Bay Pond Partners, L.P; Boeing Co., Pension Arm; Brandes Canada Global Equity Unit Trust; Brandes Global Balanced Fund; Brandes Global Equity Fund (Can); Brandes Investment Funds PLC-Brandes U.S. Equities Fund; Brandes Investment Partners & Co.; Brandes Investment Partners, L.P.; Brandes U.S. Equity Fund (Can); Brandywine Global Investment Management, LLC; Brisbane City Council; Building Trades United Pension Trust Fund; California Pacific Medical Center; California State Automobile Association, Pension Arm; Canadian Medical Association; Capital Research and Management Company; Cif All Cap Equity Fund; City Of Winston-Salem; Claymore Securities, Inc.; Co-operative Superannuation Society Pension Plan; Colleges of Applied Arts and Technology Pension Plan; Columbia Global Value Fund; Communities Foundation of Texas; Conocophillips Retirement Plan; Consolidated Rail Corporation; Conventum Asset Management S.A.; Core Allocation Plus Trust; Counsel Group of Funds, Inc.; Counsel Select America (Can); Counsel World Managed Portfolio; D. E. Shaw Investment Management, L.L.C.; D. E. Shaw Oculus Portfolios, L.L.C.; D.E. Shaw Valence Portfolios LLC; Derbyshire County Council; Desjardins Asset Management; Desjardins Global Asset Management Inc.; Deutsche Investment Management Americas Inc.; DG Capital Management, Inc.; DGAM U.S. Equity Fund L.P.; Diversified Investment Advisors, Inc.; Doris Duke Foundation, Endowment; Dow Chemical Co, Pension Arm; Dow Employees Pension Plan; Dreman Contrarian Large Cap Value Fund; Dreman Value Management, L.L.C.; Dreman/Claymore Dividend & Income Fund; DWS Dreman Concentrated Value Fund; DWS Dreman High Return Equity Fund; DWS Dreman High Return Equity VIP; DWS Dreman Value Income Edge Fund, Inc.; EARNEST Partners, LLC; Electronic Data Systems Corporation; Emerson Electric Co.; Energy Future Holdings Corporation; Engineering Industries Pension Fund; EQ/Mutual Shares; Equipsuper Superannuation Fund; Erie Indemnity Co.; Erie Insurance Exchange; Evangelical Lutheran Church in America Board of Pensions; Exel plc; Farallon Capital Institutional Partners II, L.P.; Farallon Capital Institutional Partners III, L.P.; Farallon Capital Institutional Partners, L.P.; Farallon Capital Management, L.L.C.; Farallon Capital Offshore Investors II, L.P; Farallon Capital Partners, L.P.; Fidelity Advisor Balanced Fund; Fidelity Advisor Dividend Growth Fund; Fidelity Advisor Financial Services Fund; Fidelity Advisor High Income Advantage Fund; Fidelity Advisor Large Cap Fund; Fidelity Advisor Leveraged Company Stock Fund; Fidelity Advisor Series I - Fidelity Advisor Value Strategies Fund; Fidelity Advisor Series VIII - Fidelity Advisor Global Capital Appreciation Fund; Fidelity Advisor Value Leaders Fund; Fidelity Central Investment Portfolios LLC - Fidelity Financials Central Fund; Fidelity Commonwealth Trust - Fid |
- |
- |
| - |
OSI Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| 3/18/2008 |
Baxter International Inc. |
Buyback |
- |
- |
- |
| - |
Affymax, Inc. |
Shelf Registration |
- |
- |
- |
| - |
Affymax, Inc. |
Shelf Registration |
- |
- |
- |
| - |
Acorda Therapeutics, Inc. |
Shelf Registration |
- |
- |
- |
| 3/12/2008 |
Novo Nordisk A/S |
Buyback |
- |
- |
- |
| - |
Altus Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| - |
Celgene Corporation |
Shelf Registration |
- |
- |
- |
| 3/6/2008 |
Akzo Nobel NV |
Buyback |
- |
- |
- |
| 3/6/2008 |
Biovator AB |
Private Placement |
ALMI Företagspartner Stockholm AB; AstraZeneca plc; IBL Gesellschaft für Immunchemie und Immunbiologie mbH; LinkMed AB; Linköpings universitet; Medicago Inc. |
- |
- |
| 3/3/2008 |
Serenex, Inc. |
Merger/Acquisition |
Pfizer Inc. |
- |
- |
| 2/26/2008 |
Biogen Idec Inc. |
Public Offering |
- |
- |
- |
| 2/26/2008 |
Biogen Idec Inc. |
Public Offering |
- |
- |
- |
| - |
Biogen Idec Inc. |
Shelf Registration |
- |
- |
- |
| 2/21/2008 |
Imaginatik PLC |
Private Placement |
Pfizer Inc. |
- |
- |
| 2/20/2008 |
Encysive Pharmaceuticals Inc. |
Merger/Acquisition |
Pfizer Inc. |
380 |
347 |
| 2/20/2008 |
Acceleron Pharma, Inc. |
Private Placement |
Celgene Corporation |
- |
- |
| 2/15/2008 |
Q Therapeutics, Inc. |
Private Placement |
EPIC Ventures; Invitrogen Corp.; Salt Lake Life Science Angels, Investment Arm; Toucan Capital Corp.; Toucan Capital Fund II, L.P.; University Of Utah Research Foundation; vSpring Capital |
- |
- |
| - |
Polynt S.p.A. |
Merger/Acquisition |
InvestIndustrial Holdings Limited |
347 |
437 |
| - |
Vertex Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| 2/11/2008 |
Vertex Pharmaceuticals Inc. |
Public Offering |
- |
- |
- |
| 2/11/2008 |
Vertex Pharmaceuticals Inc. |
Public Offering |
- |
- |
- |
| - |
Vertex Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| 2/6/2008 |
Acorda Therapeutics, Inc. |
Public Offering |
- |
- |
- |
| - |
Acorda Therapeutics, Inc. |
Shelf Registration |
- |
- |
- |
| 2/1/2008 |
Neurorecovery, Inc., Aminopyridine and Pre-Clinical Assets |
Merger/Acquisition |
Acorda Therapeutics, Inc. |
3 |
3 |
| 2/1/2008 |
Amgen Kabushiki Kaisha |
Merger/Acquisition |
Takeda Pharmaceutical Co. Ltd. |
- |
- |
| 1/23/2008 |
Pfizer Inc. |
Buyback |
- |
- |
- |
| 1/22/2008 |
Celgene Corporation |
Public Offering |
- |
- |
- |
| 1/18/2008 |
Pfizer Inc., Manufacturing Facility in Italy |
Merger/Acquisition |
Actavis Group Hf. |
- |
- |
| 1/15/2008 |
Aerogen Inc. |
Merger/Acquisition |
- |
- |
- |
| 1/10/2008 |
CellzDirect, Inc. |
Merger/Acquisition |
Invitrogen Corp. |
57 |
57 |
| 1/8/2008 |
Biogen Idec Inc., PDL BioPharma, Inc., Licensing for Volociximab (M200) |
Merger/Acquisition |
Ophthotech Corporation |
- |
- |
| 1/8/2008 |
Amgen Inc., Worldwide Rights Of AMG 623 |
Merger/Acquisition |
Anthera Pharmaceuticals, Inc. |
- |
- |
| 1/7/2008 |
Isis Pharmaceuticals, Inc., Exclusive Worldwide License Of Mipomersen |
Merger/Acquisition |
Genzyme Corp. |
1,750 |
1,750 |
| 1/7/2008 |
ISIS Pharmaceuticals Inc. |
Private Placement |
Genzyme Corp. |
- |
- |
| 1/4/2008 |
OSI Pharmaceuticals Inc. |
Buyback |
- |
- |
- |
| - |
Cubist Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| - |
Cubist Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| 1/3/2008 |
OSI Pharmaceuticals Inc. |
Private Placement |
- |
- |
- |
| 12/31/2007 |
Heumann PCS GmbH |
Merger/Acquisition |
Fareva SA |
- |
- |
| 12/27/2007 |
Polynt S.p.A. |
Merger/Acquisition |
InvestIndustrial Holdings Limited |
105 |
446 |
| 12/24/2007 |
Illumigen Biosciences, Inc. |
Merger/Acquisition |
Cubist Pharmaceuticals Inc. |
358 |
357 |
| 12/21/2007 |
Hennecke Gmbh |
Merger/Acquisition |
Meyer Burger Technology AG |
14 |
20 |
| - |
OSI Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| 12/18/2007 |
CovX Research LLC |
Merger/Acquisition |
Pfizer Inc. |
- |
- |
| 12/15/2007 |
USB Corporation |
Merger/Acquisition |
Affymetrix Inc. |
75 |
75 |
| 12/14/2007 |
TcLand SA |
Private Placement |
Auriga Partners; Beviguen; Debioinnovation; Genzyme Corp.; Quest for Growth NV; Quest Management NV |
- |
- |
| 12/12/2007 |
Lonza Group AG |
Merger/Acquisition |
- |
548 |
8,270 |
| - |
Harvard Bioscience Inc. |
Merger/Acquisition |
Skystone Capital Management, L.P. |
133 |
143 |
| 12/6/2007 |
Pfizer Inc. |
Public Offering |
- |
- |
- |
| 12/6/2007 |
Caris MPI |
Merger/Acquisition |
Caris Diagnostics, Inc. |
40 |
40 |
| 12/6/2007 |
Harvard Bioscience Inc. |
Buyback |
- |
- |
- |
| 12/4/2007 |
Baxter International Inc. |
Public Offering |
- |
- |
- |
| 11/30/2007 |
Genomic Solutions Division and Maia Scientific |
Merger/Acquisition |
Digilab, Inc. |
1 |
1 |
| 11/28/2007 |
Regeneron Pharmaceuticals Inc. |
Private Placement |
Sanofi-Aventis |
- |
- |
| 11/27/2007 |
Xenome Limited |
Private Placement |
Amylin Pharmaceuticals Inc.; Queensland BioCapital Fund; Queensland BioCapital Funds Pty Ltd. |
- |
- |
| 11/16/2007 |
Amgen Inc. |
Public Offering |
- |
- |
- |
| 11/15/2007 |
Coley Pharmaceutical Group, Inc. |
Merger/Acquisition |
Pfizer Inc. |
230 |
143 |
| - |
Cephalon Inc. |
Shelf Registration |
- |
- |
- |
| 11/13/2007 |
Affymetrix Inc. |
Public Offering |
- |
- |
- |
| - |
Affymetrix Inc. |
Shelf Registration |
- |
- |
- |
| - |
Vertex Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| - |
Acorda Therapeutics, Inc. |
Shelf Registration |
- |
- |
- |
| 10/30/2007 |
Hennecke Gmbh |
Merger/Acquisition |
ADCURAM Industriekapital AG |
- |
- |
| 10/22/2007 |
Gilead Sciences Inc. |
Buyback |
- |
- |
- |
| 10/16/2007 |
Kaketsu Ken, K.k., ADAMTS13 |
Merger/Acquisition |
Baxter International Inc. |
- |
- |
| 10/11/2007 |
Panlab, S.L. |
Merger/Acquisition |
Harvard Bioscience Inc. |
5 |
5 |
| 10/11/2007 |
Nobilas International B.V. |
Merger/Acquisition |
Innovation Group plc |
1 |
1 |
| - |
Imclone Systems Inc. |
Shelf Registration |
- |
- |
- |
| 10/9/2007 |
NPS Pharmaceuticals, Inc., Assets Related To mGluR Collaboration |
Merger/Acquisition |
AstraZeneca plc |
30 |
30 |
| 10/8/2007 |
QLT Plug Delivery, Inc. |
Merger/Acquisition |
QLT Inc. |
101 |
101 |
| 9/27/2007 |
Lonza Singapore Pte. Ltd. |
Merger/Acquisition |
Perstorp AB |
138 |
138 |
| - |
Alexion Pharmaceuticals, Inc. |
Shelf Registration |
- |
- |
- |
| 9/26/2007 |
GlobeImmune, Inc. |
Private Placement |
Adams Street Partners, LLC; Biogen Idec New Ventures; Boston Life Science Venture Corp.; Celgene Corporation; China Investment & Development Co. Ltd.; Eminent Venture Capital Corp.; G C & H Investments; HealthCare Ventures LLC; Lilly Ventures; Medica Venture Partners; Mellon Family Investment Co. Vi; Morgenthaler; Pac-Link Management Corp.; Partners Healthcare System, Inc.; Richard King Mellon Foundation, Endowment Fund; Sequel Venture Partners; Wexford Capital LLC; WRF Capital; Yasuda Enterprise Development 1 L.P. |
- |
- |
| 9/13/2007 |
PTC Therapeutics, Inc. |
Private Placement |
Celgene Corporation |
- |
- |
| 9/11/2007 |
Biotest Pharmaceuticals Corporation |
Merger/Acquisition |
Biotest AG |
185 |
185 |
| 9/5/2007 |
Kelaroo, Inc. |
Private Placement |
Amylin Pharmaceuticals Inc. |
- |
- |
| 8/31/2007 |
AstraZeneca plc |
Public Offering |
- |
- |
- |
| - |
AstraZeneca plc |
Shelf Registration |
- |
- |
- |
| 8/30/2007 |
American Medical Instruments Holdings, Inc. |
Merger/Acquisition |
- |
2 |
2 |
| 11/18/2007 |
Pharmion Corp. |
Merger/Acquisition |
Celgene Corporation |
2,721 |
2,603 |
| 8/23/2007 |
ECR Pharmaceuticals, Amrix |
Merger/Acquisition |
Cephalon Inc. |
100 |
100 |
| 8/22/2007 |
CSL Ltd. |
Buyback |
- |
- |
- |
| 8/20/2007 |
Encysive Pharmaceuticals Inc. |
Private Placement |
Enable Capital Management; Enable Growth Partners, LP; Enable Opportunity Partners LP; Hudson Bay Capital Management LP; Hudson Bay Fund LP; Hudson Bay Overseas Fund Ltd; Pierce Diversified Strategy Master Fund, LLC |
- |
- |
| - |
Imperial Chemical Industries plc |
Merger/Acquisition |
Akzo Nobel NV |
9,164 |
7,866 |
| - |
Amylin Pharmaceuticals Inc. |
Shelf Registration |
- |
- |
- |
| 8/7/2007 |
Grifols, S.A. |
Merger/Acquisition |
FIL Limited. |
- |
- |
| 8/1/2007 |
Invitrogen Corp. |
Buyback |
- |
- |
- |